The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AGN-PC-00HPQR     17-ethynyl-17-hydroxy-13- methyl-1,2,6,7,8...

Synonyms: NSC9564, Oprea1_606355, AC1L1IDS, BBL012124, STK730956, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Norpregneninolone


Psychiatry related information on Norpregneninolone


High impact information on Norpregneninolone


Chemical compound and disease context of Norpregneninolone


Biological context of Norpregneninolone


Anatomical context of Norpregneninolone


Associations of Norpregneninolone with other chemical compounds


Gene context of Norpregneninolone


Analytical, diagnostic and therapeutic context of Norpregneninolone


  1. Letter: Jaundice associated with norethisterone-acetate treatment of breast cancer. Langlands, A.O., Martin, W.M. Lancet (1975) [Pubmed]
  2. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Thom, M.H., White, P.J., Williams, R.M., Sturdee, D.W., Paterson, M.E., Wade-Evans, T., Studd, J.W. Lancet (1979) [Pubmed]
  3. A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Junquera, F., Feu, F., Papo, M., Videla, S., Armengol, J.R., Bordas, J.M., Saperas, E., Piqué, J.M., Malagelada, J.R. Gastroenterology (2001) [Pubmed]
  4. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. Christiansen, C., Riis, B.J. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  5. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists? Riis, B.J., Christiansen, C., Johansen, J.S., Jacobson, J. J. Clin. Endocrinol. Metab. (1990) [Pubmed]
  6. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Helmy, A. Aliment. Pharmacol. Ther. (2006) [Pubmed]
  7. Does low-dose, transdermal, norethisterone acetate reliably cause endometrial transformation in postmenopausal oestrogen-users? Fraser, D., Whitehead, M., Schenkel, L., Pryse-Davies, J. Maturitas. (1993) [Pubmed]
  8. Transdermal administration of oestrogen/progestagen hormone replacement therapy. Whitehead, M.I., Fraser, D., Schenkel, L., Crook, D., Stevenson, J.C. Lancet (1990) [Pubmed]
  9. Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Meade, T.W., Haines, A.P., North, W.R., Chakrabarti, R., Howarth, D.J., Stirling, Y. Lancet (1977) [Pubmed]
  10. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Hägglund, H., Remberger, M., Klaesson, S., Lönnqvist, B., Ljungman, P., Ringdén, O. Blood (1998) [Pubmed]
  11. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women. Eriksen, E.F., Langdahl, B., Vesterby, A., Rungby, J., Kassem, M. J. Bone Miner. Res. (1999) [Pubmed]
  12. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics. Scheffler, M.R., Colburn, W., Kook, K.A., Thomas, S.D. Clin. Pharmacol. Ther. (1999) [Pubmed]
  13. Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits. Zandberg, P., Peters, J.L., Demacker, P.N., Smit, M.J., de Reeder, E.G., Meuleman, D.G. Arterioscler. Thromb. Vasc. Biol. (1998) [Pubmed]
  14. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Irvine, G.A., Campbell-Brown, M.B., Lumsden, M.A., Heikkilä, A., Walker, J.J., Cameron, I.T. British journal of obstetrics and gynaecology. (1998) [Pubmed]
  15. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Preston, J.T., Cameron, I.T., Adams, E.J., Smith, S.K. British journal of obstetrics and gynaecology. (1995) [Pubmed]
  16. The effect of menopausal status and sequential mestranol and norethisterone on serum biochemical profiles. Moore, B., Paterson, M.E., Sturdee, D.W., Whitehead, T.P. British journal of obstetrics and gynaecology. (1981) [Pubmed]
  17. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Cameron, I.T., Leask, R., Kelly, R.W., Baird, D.T. Prostaglandins (1987) [Pubmed]
  18. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone. Trapnell, C.B., Donahue, S.R., Collins, J.M., Flockhart, D.A., Thacker, D., Abernethy, D.R. Clin. Pharmacol. Ther. (1998) [Pubmed]
  19. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. Duncan, A.C., Lyall, H., Roberts, R.N., Petrie, J.R., Perera, M.J., Monaghan, S., Hart, D.M., Connell, J.M., Lumsden, M.A. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  20. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. Larrea, F., García-Becerra, R., Lemus, A.E., García, G.A., Pérez-Palacios, G., Jackson, K.J., Coleman, K.M., Dace, R., Smith, C.L., Cooney, A.J. Endocrinology (2001) [Pubmed]
  21. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy. Raudaskoski, T., Knip, M., Laatikainen, T. Menopause (New York, N.Y.) (1998) [Pubmed]
  22. The effects of low dose norethisterone on biochemical variables in postmenopausal women. Scopacasa, F., Horowitz, M., Need, A.G., Morris, H.A., Nordin, B.E. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. (1999) [Pubmed]
  23. The effects of oestrogens and progesterone on oestrogen receptors in female rat liver. Marr, W., Elder, M.G., Lim, L. Biochem. J. (1980) [Pubmed]
  24. Clinical pharmacokinetics of contraceptive steroids. An update. Shenfield, G.M., Griffin, J.M. Clinical pharmacokinetics. (1991) [Pubmed]
  25. Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries. Cagnacci, A., Arangino, S., Draetta, F.P., Angiolucci, M., Volpe, A., Melis, G.B. Menopause (New York, N.Y.) (2000) [Pubmed]
  26. Norethisterone does not inhibit rat testis delta 5-3 beta-hydroxysteroid dehydrogenase. Spona, J. FEBS Lett. (1982) [Pubmed]
  27. Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women. Jespersen, C.M., Arnung, K., Hagen, C., Hilden, T., Nielsen, F., Nielsen, M.D., Giese, J. J. Hypertens. (1983) [Pubmed]
  28. Salivary antipyrine half-life during injectable progestagen contraception. Joshi, J.V., Gupta, K.C., Hazari, K.T., Gokral, J., Pohujani, S., Satoskar, R. Clinical pharmacokinetics. (1986) [Pubmed]
  29. Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. Seeger, H., Wallwiener, D., Mueck, A.O. Menopause (New York, N.Y.) (2001) [Pubmed]
  30. Phenobarbitone interaction with oral contraceptive steroids in the rabbit and rat. Back, D.J., Breckenridge, A.M., Crawford, F.E., Orme, M.L., Rowe, P.H. Br. J. Pharmacol. (1980) [Pubmed]
  31. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. Helle, S.I., Omsjø, I.H., Hughes, S.C., Botta, L., Hüls, G., Holly, J.M., Lønning, P.E. Clin. Endocrinol. (Oxf) (1996) [Pubmed]
  32. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin. Song, S., Chen, J.K., He, M.L., Fotherby, K. Contraception. (1989) [Pubmed]
  33. Comparative evaluation of androgen and progesterone receptor transcription selectivity indices of 19-nortestosterone-derived progestins. García-Becerra, R., Cooney, A.J., Borja-Cacho, E., Lemus, A.E., Pérez-Palacios, G., Larrea, F. J. Steroid Biochem. Mol. Biol. (2004) [Pubmed]
  34. Radiation-induced mammary tumors in virgin and parous rats administered contraceptive steroids, 17alpha-ethinylestradiol and norethisterone. Inano, H., Onoda, M., Suzuki, K., Kobayashi, H., Wakabayashi, K. Carcinogenesis (2000) [Pubmed]
  35. Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo. Bhattacharya, D., Redkar, A., Mittra, I., Sutaria, U., MacRae, K.D. Br. J. Cancer (1997) [Pubmed]
  36. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive. Beck, L.R., Pope, V.Z., Flowers, C.E., Cowsar, D.R., Tice, T.R., Lewis, D.H., Dunn, R.L., Moore, A.B., Gilley, R.M. Biol. Reprod. (1983) [Pubmed]
  37. A rapid and sensitive radioimmunoassay for norethisterone. Garza-Flores, J., Diaz-Sanchez, V., Bedolla-Tovar, N., Lozano-Ruy, A. Steroids (1983) [Pubmed]
WikiGenes - Universities